Michael C. Bibby
Impact in
- Toxicology top 2%
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Cancer, Hypoxia, and Metabolism 5
- Protease and Inhibitor Mechanisms 3
- Pharmacology 13
- Microbial Natural Products and Biosynthesis 4
- Synthesis of Organic Compounds 4
- Co-authors
- Marie SuggittJohn A. DoubleDeirdre DeVineAlison MooreWayne D. BeazleyJason H. GillPatricia A. CooperPaul M. Loadman
- Journals
- Archiv der Pharmazie (5 papers)Clinical Cancer Research (3 papers)International Journal of Oncology (3 papers)Cancer Chemotherapy and Pharmacology (3 papers)Journal of Natural Products (3 papers)
- Partner nations
- United KingdomUnited StatesDenmark
In The Last Decade
Michael C. Bibby
47 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 118
- Toxicology 78
- Microbiology 135
- Cancer Research 300
- Oncology 389
- Pharmacology 114
Countries citing papers authored by Michael C. Bibby
This map shows the geographic impact of Michael C. Bibby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Bibby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Bibby more than expected).
Fields of papers citing papers by Michael C. Bibby
This network shows the impact of papers produced by Michael C. Bibby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Bibby. The network helps show where Michael C. Bibby may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael C. Bibby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 51 | |
| 2 | 2011 | 4 | |
| 3 | 2010 | 48 | |
| 4 | 2004 | 17 | |
| 5 | 2004 | 57 | |
| 6 | 2003 | 10 | |
| 7 | Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development. | 2003 | 80 |
| 8 | 2003 | 3 | |
| 9 | 2003 | 7 | |
| 10 | 2003 | 3 | |
| 11 | 1999 | 34 | |
| 12 | 1998 | 12 | |
| 13 | 1997 | 8 | |
| 14 | 1996 | 165 | |
| 15 | 1996 | 20 | |
| 16 | 1996 | 3 | |
| 17 | 1995 | 4 | |
| 18 | 1993 | 16 | |
| 19 | 1992 | 48 | |
| 20 | 1992 | 17 |
About Michael C. Bibby
Michael C. Bibby is a scholar working on Cancer Research, Pharmacology, Aging, Oncology and Molecular Biology, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Synthesis and biological activity (7 papers), Biological Activity of Diterpenoids and Biflavonoids (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Synthesis of Organic Compounds (4 papers), DNA Repair Mechanisms (3 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Toxicology (78 citations), Microbiology (135 citations), Cancer Research (300 citations), Oncology (389 citations) and Pharmacology (114 citations). Michael C. Bibby has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Marie Suggitt, John A. Double, Deirdre DeVine, Alison Moore, Wayne D. Beazley, Jason H. Gill, Patricia A. Cooper, Paul M. Loadman, Steven D. Shnyder and Dieter Marmé. Their work appears in journals such as Archiv der Pharmazie, Clinical Cancer Research, International Journal of Oncology, Cancer Chemotherapy and Pharmacology and Journal of Natural Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.